News

On top of my grief, it felt outrageous that something so central to who I am had remained unknown to the person I loved for ...
A recent study of young adults in Israel found that a 20 mg dose of methylphenidate reduces choice impulsivity in men, but ...
Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.
Eight-year-old Bryn was a disruptive pupil. He roamed the classroom as if he owned it, asked silly questions and, given the ...
The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...
A new study from Geneva has found that adults with Attention Deficit Hyperactivity Disorder (ADHD) may be more likely to ...
July brings with it warmer weather, cookouts, and maybe some time chilling next to a body of water. Whether your summer takes you to the ocean or a kiddie pool in your backyard, here are some book ...
Pharmaceutical giant Cipla plans to enter India's weight management sector, while also bolstering its central nervous system ...
Discover a study using Mendelian randomisation to reveal a potential causal link between ADHD and childhood allergic diseases ...
Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.
Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...
Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...